全球醫藥品管理系統市場:各軟體類型、引進類型、終端用戶、地區(2018年∼2023年)

全球醫藥品管理系統市場，預計從預測期間的2018年到2023年以20％的年複合成長率發展。

本報告提供全球醫藥品管理系統市場調查，市場概要，各軟體類型、引進類型、終端用戶、地區的市場規模的變化與預測，市場趨勢，市場成長要素及阻礙因素分析，市場機會，競爭情形，主要企業的簡介等全面性資訊。

目錄

第1章 簡介

• 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

• 目前市場方案
• 波特的五力分析
  • 買方議價能力
  • 供給企業談判力
  • 新加入業者的威脅
  • 替代品的威脅
  • 競爭企業間的敵對關係

第6章 市場動態

• 市場成長要素
  • 在已開發國家醫療用IT的滲透進行
  • 提高門診病人服務的品質的醫院出資增加
• 市場阻礙因素
  • 發展中國家的投藥管理系統的認識低
  • 投藥管理系統的成本高
• 市場機會
• 主要課題

第7章 市場區隔

• 各軟體類型
  • 醫生的電腦醫令系統(CPOE)
  • 臨床決策支援系統解決方案
  • 投藥電子管理記錄
  • 庫存管理解決方案
  • 其他
• 各引進類型
  • 內部部署
  • Web為基礎
  • 雲端
• 各終端用戶
  • 醫院
  • 藥局
  • 其他
• 各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 南美

第8章 企業簡介

• Allscripts Healthcare Solutions Inc.
• ARxIUM
• Becton, Dickinson and Company
• Cerner Corporation
• GE Healthcare
• McKesson Corporation
• Medication Management Systems, Inc.
• Omnicell, Inc.
• Talyst, LLC.

第9章 市場未來展望

The Medication Management System Market is expected to register a CAGR of 9.1% during the forecast period. The rising demand for IT solutions in the healthcare sector is increasing and ultimately the adoption of healthcare IT services is increasing which is fueling the medication management system market.

Furthermore, an increase in investments by the hospitals to improve the quality of treatment services is another factor contributing to the growth of the medication management system market. According to the International Diabetes Federation, estimates that between 2019 to 2045 the global expenditures for diabetes treatment are expected to grow from USD 760 billion to USD 845 billion. Chronic diseases such as diabetes can have life-threatening cardiovascular, renal and nervous system consequences when left untreated and which is responsible for the leading causes of death worldwide. However, lack of awareness about medication management systems in the developing countries, higher costs associated with medication management systems is another factor hindering the growth of the medication management system market.

Key Market Trends

Clinical Decision Support System Solutions Segment is Expected to Hold a Major Market Share

Clinical Decision Support Systems (CDSS) refer to a healthcare IT system that is designed specifically to assist clinical decision support for healthcare professionals and physicians. CDS comprises of various tools, which helps to enhance decision-making in the clinical workflow. These tools include computerized alerts and reminders to care providers and patients, clinical guidelines, focused patient data reports and summaries, diagnostic support, and documentation templates, among other tools.

Furthermore, growing need for reducing human errors, rising demand to reduce healthcare expenditure, need for improvement in quality of care, rising chronic disease population, and more adoption rate in emerging economies are the major factors that are likely to boost the growth of the clinical decision support system solutions segment.

North America is Expected to Hold a Significant Share in the Market and is Expected to do Same During the Forecast Period

North America has dominated the medication management market owing to the robust adoption of IT in healthcare, technological advancement, an increase in the incidence of infectious and chronic diseases, and a rise in the number of prescriptions in the region that are the key factors responsible for the region's dominance.

This can be attributed to high awareness about new technologies, the presence of a large number of small- and medium-scale players who offer medication management solutions to various hospitals and pharmacies, and a shortage of primary care physicians. According to the Health Research Institute (HRI), estimated that annual percentage change in medical costs to treat patients was increased by 5.7% in 2019 which was 5.5% compared to 2017. However, it was estimated to increase by 6% by 2020. Thus, owing to above factors, North America is expected to show growth in the medication management systems market over the forecast period.

Competitive Landscape

The Medication Management System Market is fragmented competitive and consists of several major players. Market players are continuously focusing on acquisitions and mergers, provisions of solutions that are customized, and expansion of companies in untapped commercial markets. Moreover, companies are also investing huge amounts on developing new products and platforms with enhanced and improved features as a part of a commercialization strategy. In January 2018, GE, Roche entered into the partnership to develop an integrated digital diagnostics platform to improve oncology and critical care treatment.

Reasons to Purchase this report:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Enormous Data Mounting from Healthcare Industry
  • 4.2.2 Rising Number of Clinical Trials
  • 4.2.3 Government Emphasis on Clinical Research
• 4.3 Market Restraints
  • 4.3.1 Lack of Awareness and Infrastructure in Developing Countries
  • 4.3.2 High Implementation Costs
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Product Type
  • 5.1.1 Computerized Physician Order Entry
  • 5.1.2 Clinical Decision Support System Solutions
  • 5.1.3 Electronic Medication Administration Record
  • 5.1.4 Inventory Management Solutions
  • 5.1.5 Other Product Types
• 5.2 By Mode of Delivery
  • 5.2.1 Web-based
  • 5.2.2 Cloud-based
  • 5.2.3 On-premise
• 5.3 By End User
  • 5.3.1 Pharmacies
  • 5.3.2 Hospitals
  • 5.3.3 Other End Users
• 5.4 Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 A-S Medication Solutions (Allscripts Healthcare Solutions Inc)
  • 6.1.2 ARxIUM
  • 6.1.3 Becton, Dickinson and Company
  • 6.1.4 Cerner Corporation
  • 6.1.5 GE Healthcare (GE Company)
  • 6.1.6 McKesson Corporation
  • 6.1.7 Omnicell, Inc.
  • 6.1.8 Talyst, LLC (Psychiatric Solutions, Inc)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS